Anticonvulsants Flashcards

1
Q

Epilepsy

A

spontaneous episodes associated w/ loss or disturbances of consciousness, usually but not always accompanied by characteristic body movements and always excessive EEG discharge

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Seizure

A

transient alteration of behavior due to disordered, synchronous and rhythmic firing of a population of brain neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Focal or partial seizure

A

60% of epilepsies, originates in one hemisphere of brain, usually due to lesion: head trauma, tumor, stroke, hypoxia at birth, metabolic disorders, malformations, can progress to generalized seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Generalized seizures

A

originates from both hemispheres simultaneously, loss of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Status epilepticus

A

failure of seizure termination>5 mins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tonic-clonic

A

loss of consciousness w/ tonic stiffening followed by clonic muscle activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

isolated tonic

A

mostly in children, increased tone in extensors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

isolated clonic

A

mostly in small children and babies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Atonic

A

abrupt loss of all muscle tone; patients fall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Absence

A

hardest to treat, commonly seen in children, brief loss of awareness and behavioral arrest, inhibition of GABA receptors, activation of T-type Ca current leading to hypperpolerization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Myoclonic

A

sudden or split second, contraction of a muscle or group of muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lennox Gastaut syndrome

A

difficult to control seizure disorder where pt usually has myoclonic, atonic, absence and tonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pathophysiology of seizures

A

not well understood, imbalance between excitatory and inhibitory neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non-pharm treatment

A

surgery, ketogenic diet, vagal nerve stimulator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Goals of AEDs

A

decrease seizures, minimize adverse effects of seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

AEDs MOA

A

inhibit Na channels, inhibit Ca channels, potentiate K channels, increase GABA, decrease glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Barbiturates

A

Phenobarbital, primidone (Mysoline), Prntobarbital (Nembutol), Methohexital (Brevitol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Barbiturates MOA

A

binds to allosteric modulation site that is present at a/B subunits of GABA, coupled to Cl channels they open in presence of GABA permitting influx of Cl and hyperpolerizes cell, barbiturates cause cl channel to stay open

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Phenobarbitol

A

effective in tonic-clonic, and focal seizures, DOC for neonatal seizures, IV/PO, cheap, can be monitored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ADRs of phenobarbitol

A

sedation, depression of mood, cognitive impairment, hepatoxicity, lots of DIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Primidone (Mysoline)

A

major metabolite of phenobarbitol, DOC for essential tremor, second line for focal and tonic clonic, very sedating, sometimes status epilepticus, primary use for pentobarbital coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Phenytoin (Dilantin) MOA

A

Na channel blocker that binds the inactive channel and inc the time it takes to recover to the active state, prolonged recovery time limits high-freq firing, some use in antiarrythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Phenytoin (Dilantin) indications

A

focal w/and w/out 2nd generalization, sometimes primary generalized tonic clonic, eizure prevention following neurosurgery, not effective for atonic, absence or myoclonic seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Phenytoin (Dilantin)

A

IV/PO must drug monitor, narrow therapeutic index, nonlinear kinetics, status: load w/ 15-20 mg/kg IV/PO, maintenance 100 mg PO TID to start, normal levels 10-10 mcg/ml, adjust for protein, many DI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Phenytoin ADRs

A

sedation, nausea, nystagmus, dizziness, cog impair, ataxia, SJS, hepatic toxicity aplastic anemia, gingival hyperplasia, hirsutism, folate defiency and osteopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Fosphenytoin (Cerebyx)

A

IV prodrug of phenytoin, less ADRs, infused faster 150 mg/min, loading does 100 mg IV, IV/IM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Benzodiazepines

A

Diazepam (Valium), Lorazepam (Ativan), Midazolam (Versed), Clonazepam (Klonipin), Clobazam (Onfi)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Benzo MOA

A

bind to allosteric modulation site of GABA receptor, GABA linked to Cl channel, when GABA and Benzos are bound to receptors they follow more frequent opening of channels, and thus more hyperpolarization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Clonazepam (Klonopin)

A

only PO, for myoclonic, atypical absence seizures of lennox Gastaut syndrome, severe ADRs limit use, CIV controlled

30
Q

Clonazepam (Klonopin) dose

A

.5-2 mg PO BID

31
Q

Clobazam (Onfi)

A

only PO, for adjunct Lennox-Gastaut, epilepsy, CIV controlled, ADRs- somnolence, pyrexia, lethargy, upper respiratory infxn

32
Q

Clobazam (Onfi) dose

A

based on wt, end dose 10-20 mg PO BID

33
Q

Diazepam (Valium)

A

PO, IV and rectal (acute at home), CIV controlled, many active metabolites, long T1/2

34
Q

Diazepam (valium) dose

A

10-20 mg, rectal .2 mg/kg

35
Q

Lorazepam (Ativan)

A

IV/PO, IV DOC for status, also acute seizures, PO rare for chronic, better options

36
Q

Lorazepam (Ativan) dose

A

2 mg IV until controlled, maintenence dose .5 mg PO BID

37
Q

Midazolam (Versed)

A

IV, refractory status last line, short T1/2 requires continuous infusion to maintain therapeutic levels, usually used for sedation

38
Q

Succinimides

A

Ethosuximide (Zarontin), Methsuximide (Celontin)

39
Q

Ethosuximide (Zarontin)

A

first absence seizure med, unknown MOA (block voltage dependent T-type Ca channels in thalamus), only effective for treatment of absence (DOC)

40
Q

ADRs of Ethosuximide (Zarontin)

A

GI intolerance, sedation, dizziness, irritability, aggression, and extrapyramindal symptoms

41
Q

The “Zepine” MOA

A

prolongs refractory period of voltage gated Na channels, inhibits voltage gated Ca channels, limits sustained high frequency neuronal firing of action potentials in a manner similar to PHT

42
Q

Carbamazepine (Tegretol)

A

for partial seizures, generalized tonic/clonic, trigeminal neuralgia, acute mania, migraines, not for absence, myoclonic or atonic seizures, lots of DI, induces its own metabolism

43
Q

Carbamazepine (Tegretol) dose and ADRs

A

200 mg BID, hyponatremia, dizziness, somnolence, ataxia, nystagmus, nausea, diplopia, SJS, leukopenia, agranulocytosis, aplastic anemia, hepatic toxicity

44
Q

Oxycarbazepine (Trileptal)

A

developed to limit ADRs, metabolized to monohydroxy derivative which exerts the anticonvulsant effect, for monotherapy of add-on for focal seizures, few DI

45
Q

Oxycarbazepine (Trileptal) ADRs and dose

A

150 mg PO BID-600 PO BID (2400mg/day max), dizziness, somnolence, ataxia, nystagmus, nausea, diplopia, rash, hyponatremia

46
Q

Eslicarbazepine (Apriom)

A

brand new, 400-800 mg PO daily, for partial onset seizures as adjunct, same ADR and DIs

47
Q

Valproate

A

Valproic Acid (Depakene), Divalproex (Depakote), IV/PO, broad spectrum, tonic/clonic, absense, myoclonic, focal, status, mania, migraine prevention/tx, many DI w/ other AEDs

48
Q

Valproate MOA

A

inc GABA at synaptic sites, inc synthesis and dec degradation, reduced sustained rapid firing consistent w/ effect on Na channels, reduces excitation mediation by NMDA type glutamate receptors, blocks voltage dependent T-type Ca in peripheral ganglion

49
Q

Valproate Dose

A

initial 10-15 mg/kg/day, load 1000 mg IV, max 50-60 mg/kg/day, normal maintenance 500mg PO BID, normal therapeutic 50-100 mcg/ml

50
Q

Valproate ADRs

A

GI upset, sedation, cog impairment, ataxia, dizziness, weight gain, hair loss, hepatotoxic, pancreatitis, thrombocytopenia, encephalopathy, teratogenicity, PCOS

51
Q

Felbamate (Felbatol)

A

Na channel blocker, non-NMDA glutamate receptor antagonist, use for focal seizures, Lennox-Gastaut syndrome, atonic seizures, use limited by ADRs

52
Q

Gabapentin (Neurontin)/Pregabalin (Lyrica)

A

increases GABA synthesis, not very effective as anticonvulsant, for neuropathic pain, renally eliminated, 300 mg PO BID up to 1200 mg PO TID, gaba very sedating, pregabalin not as much (but dea controlled?)

53
Q

Lamotrigine (Lamictal) MOA

A

blocks voltage dependent Na channels leading to decrease in glutamate release, blocks influx through voltage dependent Ca channel, enhancing hyperpolarizing K current

54
Q

Lamotrigine (Lamictal) uses and ADRs

A

monotherapy or add on for all seizure, DOC bipolar, DOC during pregnancy, mood-elevating, dizziness, migraines, tremors, SJS (but not if titrate slowly)

55
Q

Topiramate (Topamax) MOA

A

exact MOA unknown, likely effects Na channels, glutamate receptors and GABA

56
Q

Topiramate (Topamax) Uses/Dose

A

25 mg PO BID up to 400 mg/day, monotherapy/add on for focal/ tonic/clonic, add on for lennox gastaut, ineffective for ansence, migraine prevention, wt loss

57
Q

Topiramate (Topamax) ADRs

A

Cog impairment, sedation, behavior symptoms, peripheral paresthesis, nephrolithiasis, angle-closure glaucoma

58
Q

Zonisamide (Zonegran)

A

reduces current through voltage-dependent Na channels, impairs high-freq firing of action potentials, blocks T-type Ca channels, used for mono/add on for generalized seizures

59
Q

Levetiracetam (Keppra)

A

Unknown MOA, but unique, 500 mg PO BID up to 3000mg/day, IV/PO, focal, myoclonic, add on for status, seizure prevention in brain tumors, renally eliminated, no known DI, frequent in peds

60
Q

Levetiracetam (Keppra)

A

generally well tolerate, does not need to be titrated, fatigue, irritability, psychosis, depression

61
Q

Vigabatrin (Sabril)

A

inhibits GABA transaminase, inc GABA, for focal/ infantile spasms (DOC), BBW for vision loss

62
Q

Ezogabine (Potiga)

A

unique MOA, neuronal K channel opener, stabilizes channels in open formation resulting in suppression of epileptic activity, for partial seizures, new safety alert for vision loss

63
Q

Lacosamide (Vimpat)

A

slow inactivation of voltage-gate Na channels, indicated for partial onset seizures, IV/PO, neuropathic pain, dizziness, HA, nausea, diplopia, dose dependent PR interval prolongation

64
Q

Rufinamide (Banzel)

A

prolongs refractory period of voltage-gated Na channels, for lennox-gastaut in pts >4 yo, cause sedation, nausea, HA, valproic acid will inhibit metabolism, decrease dose if using together

65
Q

Generalized tonic clonic DOC

A

valproate, Levetiracetam, Fosphenytoin, Lorazepam, also Phenobarbital, Carbamazepine, Oxcarbazepine, phenytoin, topiramate

66
Q

General absence DOC

A

ethosuximide, valproate, also levetiracetam, clonazepam, lamotrigine

67
Q

Focal or partial DOC

A

carbamazepine, Oxcarbazepine, levetiracetam, also phenobarbital, phenytoin, topiramate, lacosamide

68
Q

Myotonic DOC

A

valproate, levetiracetam, also rufinamide, clobazam

69
Q

Status epilepticus

A

Lorazepam, Diazepam, also fosphenytoin or phenobarb for prolonged

70
Q

Lennox gastaut

A

valproate also clobazam, topiramate, rufinamide